Chuck Grassley actually said...
In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.
Context
Grassley discusses findings from an investigation into insulin pricing.
03/29/2023